Literature DB >> 8514387

Cytokine response of T-cell subsets from Brucella abortus-infected mice to soluble Brucella proteins.

Y Zhan1, J Yang, C Cheers.   

Abstract

Hot saline extracts of Brucella abortus 19 were separated by successive differential precipitation with 50 and 70% ammonium sulfate, yielding fractions SBP50, with predominantly 36-kDa proteins and a number of medium-sized proteins (26 to 33 kDa), and SBP70, with 14-kDa and lower-molecular-mass proteins. Both fractions stimulated specifically proliferation and cytokine production by spleen cells from brucella-infected mice, although the activity of SBP50 was much higher than that of SBP70. Further separation of SBP50 by a DEAE-Sepharose column resulted in three distinct subfractions which were confirmed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The three subfractions were analyzed for their abilities to induce lymphocytes to proliferate and produce cytokines. The three subfractions were all active but with characteristic differences in magnitude. Subfraction 1 stimulated moderate proliferation, high interleukin 6 (IL-6) production, and relatively low production of gamma interferon (IFN-gamma). Subfraction 2 was the strongest stimulus for proliferation and production of IL-6 and IFN-gamma, while subfraction 3 stimulated moderate cell proliferation, a high level of IFN-gamma, and a low level of IL-6. IL-2 production stimulated by the three subfractions was similar. SBP50 and all three subfractions stimulated purified T cells of both CD4+ and CD8+ subsets to produce IFN-gamma. The production of IFN-gamma by CD8+ T cells to brucella antigens was enhanced with exogenous IL-2.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8514387      PMCID: PMC280929          DOI: 10.1128/iai.61.7.2841-2847.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

1.  Activation of macrophages to inhibit proliferation of Mycobacterium tuberculosis: comparison of the effects of recombinant gamma-interferon on human monocytes and murine peritoneal macrophages.

Authors:  G A Rook; J Steele; M Ainsworth; B R Champion
Journal:  Immunology       Date:  1986-11       Impact factor: 7.397

2.  Intracellular growth of Listeria monocytogenes as a prerequisite for in vivo induction of T cell-mediated immunity.

Authors:  P Berche; J L Gaillard; P J Sansonetti
Journal:  J Immunol       Date:  1987-04-01       Impact factor: 5.422

3.  T lymphocytes respond to solid-phase antigen: a novel approach to the molecular analysis of cellular immunity.

Authors:  D B Young; J R Lamb
Journal:  Immunology       Date:  1986-10       Impact factor: 7.397

4.  Comparison of living and nonliving vaccines for Brucella abortus in BALB/c mice.

Authors:  J A Montaraz; A J Winter
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

5.  Protection of mice against the intracellular bacterium Listeria monocytogenes by recombinant immune interferon.

Authors:  A F Kiderlen; S H Kaufmann; M L Lohmann-Matthes
Journal:  Eur J Immunol       Date:  1984-10       Impact factor: 5.532

Review 6.  Characterization of the murine antigenic determinant, designated L3T4a, recognized by monoclonal antibody GK1.5: expression of L3T4a by functional T cell clones appears to correlate primarily with class II MHC antigen-reactivity.

Authors:  D P Dialynas; D B Wilde; P Marrack; A Pierres; K A Wall; W Havran; G Otten; M R Loken; M Pierres; J Kappler
Journal:  Immunol Rev       Date:  1983       Impact factor: 12.988

7.  Inhibition of B lymphocyte activation by interferon-gamma.

Authors:  D S Reynolds; W H Boom; A K Abbas
Journal:  J Immunol       Date:  1987-08-01       Impact factor: 5.422

Review 8.  Human brucellosis.

Authors:  E J Young
Journal:  Rev Infect Dis       Date:  1983 Sep-Oct

9.  Requirement of endogenous interferon-gamma production for resolution of Listeria monocytogenes infection.

Authors:  N A Buchmeier; R D Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

10.  Immune response of cattle to Brucella abortus outer membrane proteins measured by lymphocyte blastogenesis.

Authors:  C L Baldwin; D R Verstreate; A J Winter
Journal:  Vet Immunol Immunopathol       Date:  1985-08       Impact factor: 2.046

View more
  25 in total

1.  Cloning of a Brucella melitensis group 3 antigen gene encoding Omp28, a protein recognized by the humoral immune response during human brucellosis.

Authors:  L E Lindler; T L Hadfield; B D Tall; N J Snellings; F A Rubin; L L Van De Verg; D Hoover; R L Warren
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  Tumor necrosis factor alpha and interleukin-12 contribute to resistance to the intracellular bacterium Brucella abortus by different mechanisms.

Authors:  Y Zhan; Z Liu; C Cheers
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

3.  Protective immunity elicited by a divalent DNA vaccine encoding both the L7/L12 and Omp16 genes of Brucella abortus in BALB/c mice.

Authors:  Deyan Luo; Bing Ni; Peng Li; Wei Shi; Songle Zhang; Yue Han; Liwei Mao; Yangdong He; Yuzhang Wu; Xiliang Wang
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

4.  Characterization of specific immune responses of mice inoculated with recombinant vaccinia virus expressing an 18-kilodalton outer membrane protein of Brucella abortus.

Authors:  R Vemulapalli; S Cravero; C L Calvert; T E Toth; N Sriranganathan; S M Boyle; O L Rossetti; G G Schurig
Journal:  Clin Diagn Lab Immunol       Date:  2000-01

5.  Recombinant L7/L12 ribosomal protein and gamma-irradiated Brucella abortus induce a T-helper 1 subset response from murine CD4+ T cells.

Authors:  S C Oliveira; Y Zhu; G A Splitter
Journal:  Immunology       Date:  1994-12       Impact factor: 7.397

6.  Subcellular fractions of Brucella ovis distinctively induce the production of interleukin-2, interleukin-4, and interferon-gamma in mice.

Authors:  E Salas-Téllez; A Núñez del Arco; V Tenorio; E Díaz-Aparicio; M de la Garza; F Suárez-Güemes
Journal:  Can J Vet Res       Date:  2005-01       Impact factor: 1.310

7.  Protection of mice against Brucella abortus 544 challenge by vaccination with recombinant OMP28 adjuvanted with CpG oligonucleotides.

Authors:  Purushottam Kaushik; Dhirendra K Singh; S Vinoth Kumar; Ashok K Tiwari; Gunjan Shukla; Shanker Dayal; Pallav Chaudhuri
Journal:  Vet Res Commun       Date:  2009-12-16       Impact factor: 2.459

8.  Cloning and sequencing of yajC and secD homologs of Brucella abortus and demonstration of immune responses to YajC in mice vaccinated with B. abortus RB51.

Authors:  R Vemulapalli; A J Duncan; S M Boyle; N Sriranganathan; T E Toth; G G Schurig
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

9.  Specific bovine brucellosis diagnosis based on in vitro antigen-specific gamma interferon production.

Authors:  V Weynants; J Godfroid; B Limbourg; C Saegerman; J J Letesson
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

10.  A DNA vaccine encoding Cu,Zn superoxide dismutase of Brucella abortus induces protective immunity in BALB/c mice.

Authors:  Angel A Oñate; Sandra Céspedes; Alex Cabrera; Rodolfo Rivers; Andrés González; Carola Muñoz; Hugo Folch; Edilia Andrews
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.